Award

Using crystallography to answer questions of structure and function

Caroline Soliman wins JBC/Tabor Young Investigator Award
Kerri Beth  Boggs
March 01, 2019

Caroline Soliman discovered her love for lab work as an undergraduate studying biomedical science at Monash University in Melbourne, Australia. She thrived on doing hands-on work to answer the question “What’s my goal, and how am I going to get there?”

 

Caroline SolimanThe findings of Caroline Soliman’s team are crucial for understanding the function of carbohydrate-binding human antibodies as potential microbial therapeutics.

Now a graduate student at the Royal Melbourne Institute of Technology, or RMIT, Soliman won a 2019 Journal of Biological Chemistry/Herbert Tabor Young Investigator Award for her work on the structural characterization of antibody candidates that recognize carbohydrates for immunotherapy for infection.

Soliman earned an honors degree at Monash University through the Burnet Institute. For her thesis, she worked with Paul Ramsland, now her dissertation mentor, to develop a peptide-based inhibitor to mimic the binding of a microbial protein to immunoglobulin A. The project sparked an interest in crystallography.

“I gained an appreciation for the importance of structure in terms of function,” she said.

After a short break from research, Soliman returned to Ramsland’s lab for her doctoral training at RMIT. Together, they crafted a project with translational benefits and an international collaboration with Gerald Pier of Harvard Medical School that would give Soliman the chance to develop her crystallography skills.

“My supervisor has been very supportive and encouraging,” she said, adding that Ramsland helped her navigate the roadblocks of learning crystallography, teaching her how to collect data from the Australian Synchrotron and walking her through the process of solving a crystal structure.

When not solving crystal structures, Soliman can be found in the kitchen baking cakes, tarts and other sweet treats. She also enjoys reading, swimming at the beach and spending time with her family in Melbourne.

After completing her Ph.D., Soliman hopes to pursue a career in research and to teach immunology.

“It’s really important to do something you enjoy,” she said.

Fighting antibiotic resistance with antibodies

Antibiotics are used to fight bacterial infections, but antibiotic resistance has created a need for alternative therapies. Many of the antibiotic-resistant bacteria prioritized for therapeutic development are known to form biofilms, sticky aggregations of microbes that act as an additional barrier against antibacterial therapies.

Therapeutic antibodies are a strong candidate to overcome both antibiotic resistance and barriers such as bacterial biofilms. Humans typically develop protective antibodies to bacterial carbohydrates as a result of infection, so researchers have focused on carbohydrate-binding antibodies. Specifically, the human antibody F598 is being tested in the clinical setting because it can elicit protective activities after binding to the microbial carbohydrate poly-N-acetyl-D-glucosamine, or PNAG, which is a polymer of N-acetyl-D-glucosamine, or GlcNAc, units.

To understand how this antibody targets PNAG, Caroline Soliman and colleagues defined the structural basis for recognition of PNAG by F598. They determined crystal structures for the antibody-binding fragment, or Fab, of F598 and its complexes with two carbohydrates, GlcNAc and a PNAG oligosaccharide. They found that the Fab binds to extracellular polysaccharide in biofilms and to PNAG on the surface of Staphylococcus aureus.

This was the first study to report the structural basis for human antibody recognition of PNAG.

Kerri Beth  Boggs

Kerri Beth Boggs is a graduate student in the biochemistry department at the University of Kentucky.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in People

People highlights or most popular articles

'Every experiment and every breakthrough matters'
Health Observance

'Every experiment and every breakthrough matters'

February 26, 2021

An interview with NYMC dean Marina K. Holz, who studies a rare disease that affects women of childbearing age.

Connecting chemistry with education
Jobs

Connecting chemistry with education

February 26, 2021

Meet Christiane Stachl, director of education, outreach and diversity at Center for Genetically Encoded Materials at UC Berkeley.

Raising awareness and funding for Pompe disease
Health Observance

Raising awareness and funding for Pompe disease

February 25, 2021

Father-turned-advocate has founded multiple organizations to support families and search for better therapies for people with rare lysosomal storage disorder.

Tributes to Barbara Gordon, ASBMB executive director, on her retirement
Stroopwafels

Tributes to Barbara Gordon, ASBMB executive director, on her retirement

February 24, 2021

Society members and former staff share their appreciation and memories of Gordon who worked at the American Society for Biochemistry and Molecular Biology for almost 50 years.

Booker edits new journal; Bumpus featured in virtual museum
Member News

Booker edits new journal; Bumpus featured in virtual museum

February 22, 2021

Awards, promotions, milestones and more. Find out what's going on in the lives of ASBMB members.

Remembering Kanfer and Barry
In Memoriam

Remembering Kanfer and Barry

February 22, 2021

Julian Kanfer was one of the first researchers to study the link between amyloid ß protein and Alzheimer’s disease. Bridgette Barry focused on how the dynamic protein matrix facilitates enzyme-based catalysis.